These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 33561380)

  • 1. Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.
    Schütz D; Conzelmann C; Fois G; Groß R; Weil T; Wettstein L; Stenger S; Zelikin A; Hoffmann TK; Frick M; Müller JA; Münch J
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L750-L756. PubMed ID: 33561380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iota-Carrageenan Inhibits Replication of SARS-CoV-2 and the Respective Variants of Concern Alpha, Beta, Gamma and Delta.
    Fröba M; Große M; Setz C; Rauch P; Auth J; Spanaus L; Münch J; Ruetalo N; Schindler M; Morokutti-Kurz M; Graf P; Prieschl-Grassauer E; Grassauer A; Schubert U
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture.
    Bansal S; Jonsson CB; Taylor SL; Figueroa JM; Dugour AV; Palacios C; Vega JC
    PLoS One; 2021; 16(11):e0259943. PubMed ID: 34797868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread.
    Bentley K; Stanton RJ
    Viruses; 2021 Nov; 13(12):. PubMed ID: 34960612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
    Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
    PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 inhibition using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray.
    Pyrć K; Milewska A; Duran EB; Botwina P; Dabrowska A; Jedrysik M; Benedyk M; Lopes R; Arenas-Pinto A; Badr M; Mellor R; Kalber TL; Fernandez-Reyes D; Schätzlein AG; Uchegbu IF
    Sci Rep; 2021 Oct; 11(1):20012. PubMed ID: 34625610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
    Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS-COV-2.
    Moakes RJA; Davies SP; Stamataki Z; Grover LM
    Adv Mater; 2021 Jul; 33(26):e2008304. PubMed ID: 34060150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
    Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic Block of SARS-CoV-2 Infection by Combined Drug Inhibition of the Host Entry Factors PIKfyve Kinase and TMPRSS2 Protease.
    Kreutzberger AJB; Sanyal A; Ojha R; Pyle JD; Vapalahti O; Balistreri G; Kirchhausen T
    J Virol; 2021 Oct; 95(21):e0097521. PubMed ID: 34406858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control.
    Hoseini-Tavassol Z; Ejtahed HS; Soroush AR; Sajjadpour Z; Hasani-Ranjbar S; Larijani B
    Infect Disord Drug Targets; 2021; 21(8):e160921191568. PubMed ID: 33602078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.
    Meister TL; Todt D; Brüggemann Y; Steinmann J; Banava S; Brill FHH; Steinmann J; Pfaender S; Steinmann E
    J Hosp Infect; 2022 Feb; 120():9-13. PubMed ID: 34752803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity.
    Hoffmann M; Hofmann-Winkler H; Smith JC; Krüger N; Arora P; Sørensen LK; Søgaard OS; Hasselstrøm JB; Winkler M; Hempel T; Raich L; Olsson S; Danov O; Jonigk D; Yamazoe T; Yamatsuta K; Mizuno H; Ludwig S; Noé F; Kjolby M; Braun A; Sheltzer JM; Pöhlmann S
    EBioMedicine; 2021 Mar; 65():103255. PubMed ID: 33676899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
    Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model.
    Alsaidi S; Cornejal N; Mahoney O; Melo C; Verma N; Bonnaire T; Chang T; O'Keefe BR; Sailer J; Zydowsky TM; Teleshova N; Romero JAF
    Mar Drugs; 2021 Jul; 19(8):. PubMed ID: 34436255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.
    Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA
    Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17β-estradiol reduces SARS-CoV-2 infection in vitro.
    Lemes RMR; Costa AJ; Bartolomeo CS; Bassani TB; Nishino MS; Pereira GJDS; Smaili SS; Maciel RMB; Braconi CT; da Cruz EF; Ramirez AL; Maricatto JT; Janini LMR; Prado CM; Stilhano RS; Ureshino RP
    Physiol Rep; 2021 Jan; 9(2):e14707. PubMed ID: 33463909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
    Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
    J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Copper Iodide Nanoparticle-Doped Film and Fabric To Inactivate SARS-CoV-2 via the Virucidal Activity of Cuprous Ions (Cu
    Takeda Y; Jamsransuren D; Nagao T; Fukui Y; Matsuda S; Ogawa H
    Appl Environ Microbiol; 2021 Nov; 87(24):e0182421. PubMed ID: 34613751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.